Formulate a three-year U.S. market entry action plan for Blink Energy technology to enter the ocular devices market.

Formulate a detailed, three-year growth strategy for FINN’s U.S. expansion, inclusive of strategy development for geographic expansion, B2B partnerships, sustainability, and competitive differentiation.

Develop a business case for Stryker Acute Care to launch a new product into the Japan market.

Determine the global market dynamics of a lunar economy.

The Pelosi-Bloom autotransfuser is a compact, portable medical device using previously FDA-approved components to rapidly transfuse a patient’s own blood during acute bleeding events in operating rooms, cardiac procedure units, ambulances and military medical units. It can be used in place of more expensive cell saver units that can be used only in hospital settings. A strategic marketing plan is needed to determine how this device should go to market.